MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $13.37
0.05 (0.38%) Open Price: 13.39

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(12/19/25) $13.39
(12/20/25) $13.32
(12/20/25) (Qty.)1,123,846
(12/19/25) $13.09
(12/19/25) $13.51
(11/30/25) $12.48
(12/07/25) $15.56
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing